Superparamagnetic core-shell nanoparticles enable co-delivery of psoralen and paclitaxel for the treatment of triple-negative breast cancer
{{output}}
Triple-negative breast cancer (TNBC) therapy with paclitaxel (PTX) is hampered by systemic toxicity, drug resistance, and poor delivery efficiency when combined with psoralen (PSO). In this study, paclitaxel/psoralen-loaded magnetic composite nanoparticles (P/... ...
